Enhancing Obesity Research with Wearable DHTs
Establishing clinical benefit is one of the most challenging and costly steps in developing a new therapy for patients with metabolic conditions such as obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH). Symptoms of these conditions can affect patients in many ways, including their physical functioning, mobility, and sleep.
With the advent of sensor-based digital health technologies (DHTs), we now have an unprecedented opportunity to remotely and continuously assess how study participants in obesity research function in their daily lives.
This digital endpoints guide provides information on wearable DHT use in obesity clinical trials and relevant regulatory guidance, a list of digital endpoints available for obesity trials, and opportunities to advance obesity research with wearable DHTs, including:
- Supporting patient-centric obesity condition drug development with easy-to-use wrist-worn technology
- Collecting evidence of health benefits beyond weight loss for obesity trials through novel digital endpoints
- Passively examining physical activity, physical functioning, sleep behavior, and vital signs in the patient’s natural environment
Advancing Obesity Research with Digital Measures
Learn more about how medical-grade wearable DHTs can help researchers and drug developers capture objective, continuous data on physical activity, physical functioning, and sleep to fill existing gaps in obesity clinical research:
